Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-19

FDA Approved: OXCARBAZEPINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals, Inc.'s supplemental application for Oxcarbazepine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)